Physician

William K Naguszewski, M.D.

According to 2025 Medicare claims, William Naguszewski, M.D. (NPI: 1134103997) practices neurology in the Rome, GA market, with the plurality of this provider's patient population coming from Floyd, GA. This provider's primary affiliated billing organization is COOSA MEDICAL GROUP (NPI: 1821046863; TIN: 581985969) and primary practice location at 30161-4999.

Naguszewski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 573 traditional Medicare patients, billed 105,860 HCPCS/CPT codes, and received $1,328,031 in Medicare payments. The top billing code was 95810 (Sleep study in sleep lab (6 years or older)). Part D data shows 8,050 prescription claims across 711 beneficiaries totaling $3,258,255 in drug costs, led by Nuplazid (Pimavanserin Tartrate). DME data shows 1,839 claims. Open Payments data shows 182 records totaling $3,716. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $274,975 to $1,328,031. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,194,777 to $3,258,255. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $90,109 and ending at $120,176.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	952	11,647	$274,975
2016	958	9,562	$246,209
2017	895	7,279	$213,703
2018	871	7,218	$205,863
2019	745	13,721	$253,952
2020	712	11,628	$206,316
2021	736	27,625	$2,329,624
2022	649	35,256	$2,040,899
2023	577	26,841	$1,291,399
2024	573	105,860	$1,328,031

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	698	7,719	$1,194,777
2016	699	7,528	$1,213,151
2017	708	7,529	$1,501,258
2018	673	7,052	$1,196,673
2019	613	7,387	$1,720,087
2020	609	7,994	$2,030,709
2021	647	7,694	$1,755,372
2022	691	7,986	$2,394,168
2023	705	8,224	$3,126,401
2024	711	8,050	$3,258,255

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	421	916	$51,787
2016	513	1,133	$42,079
2017	513	1,130	$38,450
2018	578	1,234	$43,480
2019	682	1,380	$55,752
2020	735	1,725	$73,156
2021	767	1,840	$84,287
2022	704	1,507	$70,650
2023	700	1,797	$92,626
2024	793	1,839	$97,169

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95810	Sleep study in sleep lab (6 years or older)	66	67	$168
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	58	67	$128
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	93	93	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	294	430	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	201	269	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nuplazid	Pimavanserin Tartrate	70	2,280	$334,120
Wakix	Pitolisant Hcl	23	660	$315,087
Ingrezza	Valbenazine Tosylate	23	690	$190,344
Nurtec Odt	Rimegepant Sulfate	126	3,798	$182,200
Epidiolex	Cannabidiol (Cbd)	58	1,660	$158,077

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	62	159	$16,810
A7030	Full face mask used with positive airway pressure device, each	N	67	162	$16,173
A7032	Cushion for use on nasal mask interface, replacement only, each	N	48	113	$12,721
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	96	249	$10,151
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	57	146	$8,525

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	182	$3,716	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William K. Naguszewski, M.D.?

Tedicare shows public-source Medicare data for William K. Naguszewski, M.D. (NPI 1134103997), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William K. Naguszewski, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William K. Naguszewski, M.D.?

William K. Naguszewski, M.D. is linked to COOSA MEDICAL GROUP (billing NPI 1821046863) in the available physician profile data.

Does William K. Naguszewski, M.D. have Open Payments data?

William K. Naguszewski, M.D. has 182 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.